Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Net Income (2024 - 2025)

Historic Net Income for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to -$14.2 million.

  • Beta Bionics' Net Income fell 3998.62% to -$14.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.4 million, marking a year-over-year decrease of 10292.93%. This contributed to the annual value of -$41.3 million for FY2024, which is 2133.36% down from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Net Income is -$14.2 million, which was down 3998.62% from -$16.9 million recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' Net Income ranged from a high of -$8.3 million in Q1 2024 and a low of -$16.9 million during Q2 2025